Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stemcell United Ltd. ( (AU:BP8) ) has provided an announcement.
BPH Global Ltd says its seaweed-based bio-fertiliser and bio-stimulant R&D program at Temasek Polytechnic in Singapore is nearing a key milestone, with a final report due within days. The study has tested multiple seaweed species and extraction methods, characterised bioactive compounds, and validated initial product potential for use on oil palm and rice in Southeast Asia.
Once the report is received, the company plans a technical review to identify the most promising formulations, refine development priorities with Temasek, and outline a roadmap toward commercialisation. Management frames the initiative against mounting fertiliser supply disruptions and price spikes linked to Middle East conflict and energy market volatility, arguing that seaweed-based inputs offer a sustainable, lower-impact alternative aligned with growing ESG and food security concerns.
The most recent analyst rating on (AU:BP8) stock is a Sell with a A$0.06 price target. To see the full list of analyst forecasts on Stemcell United Ltd. stock, see the AU:BP8 Stock Forecast page.
More about Stemcell United Ltd.
BPH Global Ltd is an ASX-listed company developing seaweed-based bio-fertiliser and bio-stimulant products aimed at sustainable agriculture. Its initial commercial focus is on higher-value inputs for key Southeast Asian crops, particularly oil palm and rice, leveraging locally sourced marine biomass to reduce reliance on conventional, fossil fuel-based fertilisers.
Current Market Cap: A$4.71M
Learn more about BP8 stock on TipRanks’ Stock Analysis page.